Answers are grounded in this paper and cite their sources.
L. K. P. is the cofounder of Talus Bioscience, Inc., a company developing anticancer therapeutics using mass spectrometry proteomics. Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
No takes yet. Share an insight, caveat, or question.
Lindsay K. Pino (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: